https://www.selleckchem.com/pr....oducts/gsk2830371.ht
The earlier treat stage 3 ROP is more likely to achieve better outcomes. To study the unfavorable outcomes and regression after pre-early treatment for ROP. To evaluate the progression and recurrence of ROP requiring retreatment after pre-early treatment for ROP. The data were retrieved retrospectively from the medical records of all infants who were screened and treated for ROP from January 2009 to January 2014 at a tertiary care facility. The outcomes measured the following 1. unfavorable outcomes; 2. regression of ROP; 3. progress